Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$0.24 - $0.52 $31,630 - $68,532
131,793 Added 143.79%
223,452 $75,000
Q4 2022

Feb 08, 2023

BUY
$0.22 - $1.04 $20,164 - $95,325
91,659 New
91,659 $23,000
Q2 2022

Aug 10, 2022

SELL
$1.22 - $3.05 $20,909 - $52,273
-17,139 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$2.64 - $4.67 $3,168 - $5,604
-1,200 Reduced 6.54%
17,139 $53,000
Q4 2021

Feb 14, 2022

SELL
$4.4 - $8.8 $30,408 - $60,816
-6,911 Reduced 27.37%
18,339 $82,000
Q3 2021

Nov 15, 2021

BUY
$7.44 - $13.99 $187,860 - $353,247
25,250 New
25,250 $192,000

Others Institutions Holding SMFR

About Sema4 Holdings Corp.


  • Ticker SMFR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 380,641,984
  • Market Cap $129M
  • Description
  • Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commerc...
More about SMFR
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.